EcoDrugPlus

Proteasome Subunit Beta 11

Ensembl ID : ENSAPOG00000014877
Gene Symbol: PSMB11
1 Cross references
170 Possible Orthologues:

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSAPOG00000014613
Gene Symbol: LOC110953272
3 Cross references
223 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSAPOG00000020190
Gene Symbol: LOC110963708
3 Cross references
172 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSAPOG00000011707
Gene Symbol: LOC110964534
3 Cross references
216 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSAPOG00000022262
Gene Symbol: LOC110971674
3 Cross references
214 Possible Orthologues:

Proteasome Subunit Beta Type-9-Like

Ensembl ID : ENSAPOG00000022138
Gene Symbol: LOC110971677
3 Cross references
161 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSAPOG00000014972
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSAPOG00000008727
Gene Symbol: LOC110958035
3 Cross references
203 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSAPOG00000001584
Gene Symbol: PRKCA
3 Cross references
212 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSAPOG00000015647
Gene Symbol: PRKCB
3 Cross references
210 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSAPOG00000024374
Gene Symbol: LOC110958786
3 Cross references
202 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSAPOG00000001005
Gene Symbol: PRKCD
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).